RIDE THERAPEUTICS THE MOLECULAR LOGISTICS COMPANY Trademark
Trademark Overview
On Wednesday, January 10, 2024, a trademark application was filed for RIDE THERAPEUTICS THE MOLECULAR LOGISTICS COMPANY with the United States Patent and Trademark Office. The USPTO has given the RIDE THERAPEUTICS THE MOLECULAR LOGISTICS COMPANY trademark a serial number of 98351758. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, August 19, 2024. This trademark is owned by Ride Therapeutics, Inc.. The RIDE THERAPEUTICS THE MOLECULAR LOGISTICS COMPANY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Medical and scientific research services; Research and development of drug delivery platforms; Research and development in the field of technology and micro- and nano-engineering, namely, development of drug delivery agents for use in pharmaceutical and biomedical industry; Development of new technology for others for enabling the engineering and modification of mRNA and genes for the purpose of developing molecular and cellular drug delivery agents for use in pharmaceutical and biomedical industry
General Information
| Serial Number | 98351758 |
| Word Mark | RIDE THERAPEUTICS THE MOLECULAR LOGISTICS COMPANY |
| Filing Date | Wednesday, January 10, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, August 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Medical and scientific research services; Research and development of drug delivery platforms; Research and development in the field of technology and micro- and nano-engineering, namely, development of drug delivery agents for use in pharmaceutical and biomedical industry; Development of new technology for others for enabling the engineering and modification of mRNA and genes for the purpose of developing molecular and cellular drug delivery agents for use in pharmaceutical and biomedical industry |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 9, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Ride Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02138 |
Trademark Events
| Event Date | Event Description |
| Thursday, January 11, 2024 | NEW APPLICATION ENTERED |
| Tuesday, April 30, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 7, 2024 | ASSIGNED TO EXAMINER |
| Monday, August 19, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, August 19, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, August 19, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, November 6, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, November 6, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
